mr_subhanu_saxena__1276617e

New chief executive for Cipla

pharmafile | November 30, 2012 | Appointment | Manufacturing and Production, Research and Development, Sales and Marketing Cipla, Subhanu Saxena 

Indian pharma firm Cipla has announced the appointment of Novartis’ Subhanu Saxena as its chief executive.

Saxena joins Cipla in February with 25+ years’ work experience, having worked with companies such as Citicorp, The Boston Consulting Group, and PepsiCo, across markets in Europe, North America, Africa and Asia. 

In his last assignment he led the global product strategy and commercialisation functions at Novartis Pharma AG. In this role, Saxena was a part of the global pharma executive committee with responsibility for marketing, sales, global medical affairs and health economics.

Advertisement

Cipla chairman Dr Yusuf Hamied said: “We are delighted to have found such a good match for Cipla in Subhanu. Cipla has a strong vision for the future. I am confident Subhanu will build on Cipla’s core values to deliver the next phase of growth, competitiveness and return on shareholder value.”

Related Content

bottle_of_lies_3d_bookshot_w_logo_

Diagnosing the drug supply: Exposing the bad practice of manufacturers in the developing world

The world needs cheap generic drugs and Indian manufacturers offer a steady supply. However the …

mediaphoto7_large

Cipla halts HIV drug production due to delayed government funding

Indian pharmaceutical company Cipla has halted production of its child-friendly antiretroviral HIV treatment Lopinavir (ABT-378) …

currency-166422_960_720

India’s NPPA identifies 634 non-compliant drug pricings

India’s National Pharmaceutical Pricing Authority (NPPA) has revealed that as many as 634 drugs from …

The Gateway to Local Adoption Series

Latest content